|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270 TWD | -3.57% |
|
+12.27% | +28.88% |
Alar Pharmaceuticals Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 0.8 million. Net loss was TWD 19.87 million compared to TWD 64.23 million a year ago.
Basic loss per share from continuing operations was TWD 0.35 compared to TWD 1.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +28.88% | 559M | |
| +14.78% | 78.65B | |
| +9.32% | 8.94B | |
| -10.76% | 5.16B | |
| +54.31% | 4.85B | |
| +11.19% | 4.19B | |
| -22.37% | 2.32B | |
| +11.35% | 2.29B | |
| -30.09% | 2.19B | |
| +20.63% | 2.19B |
ALAR PHARMACEUTICALS INC. 